Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Predicting the critical quality attributes of ibuprofen tablets via modelling of process parameters for roller compaction and tabletting.

Matji A, Donato N, Gagol A, Morales E, Carvajal L, Serrano DR, Worku ZA, Healy AM, Torrado JJ.

Int J Pharm. 2019 Jun 30;565:209-218. doi: 10.1016/j.ijpharm.2019.05.011. Epub 2019 May 7.

PMID:
31075438
2.

Tuning the Transdermal Delivery of Hydroquinone upon Formulation with Novel Permeation Enhancers.

Serrano DR, Gordo MJ, Matji A, González S, Lalatsa A, Torrado JJ.

Pharmaceutics. 2019 Apr 4;11(4). pii: E167. doi: 10.3390/pharmaceutics11040167.

3.

Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?

de Pablo E, Fernández-García R, Ballesteros MP, Torrado JJ, Serrano DR.

Ann Transl Med. 2017 Nov;5(22):448. doi: 10.21037/atm.2017.09.17. Review.

4.

Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.

Rolón M, Serrano DR, Lalatsa A, de Pablo E, Torrado JJ, Ballesteros MP, Healy AM, Vega C, Coronel C, Bolás-Fernández F, Dea-Ayuela MA.

Mol Pharm. 2017 Apr 3;14(4):1095-1106. doi: 10.1021/acs.molpharmaceut.6b01034. Epub 2017 Mar 3.

PMID:
28198632
5.

A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.

Luengo-Alonso C, Torrado JJ, Ballesteros MP, Malfanti A, Bersani S, Salmaso S, Caliceti P.

Int J Pharm. 2015 Nov 10;495(1):41-51. doi: 10.1016/j.ijpharm.2015.08.070. Epub 2015 Aug 28.

PMID:
26319629
6.

Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies.

Torrado JJ, Blanco M, Farré M, Roset P, García-Arieta A.

Eur J Clin Pharmacol. 2010 Jun;66(6):599-604. doi: 10.1007/s00228-010-0792-7. Epub 2010 Feb 27.

PMID:
20195587
7.

In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.

Ordóñez-Gutiérrez L, Espada-Fernández R, Dea-Ayuela MA, Torrado JJ, Bolás-Fernandez F, Alunda JM.

Int J Antimicrob Agents. 2007 Oct;30(4):325-9. Epub 2007 Jul 13.

PMID:
17631982
8.

Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole.

García JJ, Bolás F, Torrado JJ.

Int J Pharm. 2003 Jan 16;250(2):351-8.

PMID:
12527162

Supplemental Content

Loading ...
Support Center